GlucoSet is a leading brand that focuses on developing tools for glucose control in Intensive Care Units (ICUs). Their innovative products aim to reduce patient mortality, complication risks, and hospital costs associated with elevated blood glucose levels. Elevated blood glucose, also known as stress hyperglycemia, is often observed in ICU patients and can have negative effects on the body.

GlucoSet's sensors offer unique capabilities, delivering high accuracy, rapid measurements, and high sensitivity in the hypoglycemic range. This ensures that healthcare professionals can manage glucose levels effectively, balancing the risks of stress hyperglycemia and dangerous low blood glucose values (hypoglycemia). By normalizing blood glucose levels, GlucoSet's products contribute to reducing mortality rates and the risk of complications such as renal failure and sepsis, particularly for non-diabetic patients.

This not only improves patient outcomes but also leads to significant cost savings for hospitals, with a direct impact on healthcare expenditure. GlucoSet is dedicated to developing products that seamlessly integrate into the existing workflow of nurses and physicians, maximizing their acceptance and utilization of new technology. With GlucoSet's cutting-edge solutions, glucose control in ICUs can be achieved safely, efficiently, and with utmost accuracy